Role of c-Myc in nitric oxide-mediated suppression of cytochrome P450 3A4

被引:7
作者
Watabe, M [1 ]
Isogai, Y [1 ]
Numazawa, S [1 ]
Yoshida, T [1 ]
机构
[1] Showa Univ, Sch Pharmaceut Sci, Dept Biochem Toxicol, Shinagawa Ku, Tokyo 1428555, Japan
关键词
P450; Myc; NO; nitric oxide;
D O I
10.1016/j.lfs.2003.07.006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cytochrome P450 (CYP) 3A4, which is abundant in human liver and small intestine and participates in the metabolism of various drugs and xenochemicals, is known to be induced by 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) in the colon carcinoma cell line Caco-2 cells. Nitric oxide (NO) is able to inhibit CYP3A4 expression and catalytic activity. In this study, we investigated the mechanism of suppression by NO of 1,2 5(OH)(2)D-3-induced CYP3A4 expression in Caco-2 cells. Caco-2 cells were exposed for 36 h to 400 nM 1,25(OH)2D3, and the induction of CYP3A4 mRNA expression was detected by real-time PCR. Because c-Myc regulates the expression of several genes, we examined its effect on the CYP3A4 expression induced by 1,25(OH)2D3. The expression of c-myc mRNA was increased in the early stage but decreased 36 h after the treatment of Caco-2 cells with 1,25(OH)(2)D-3. The NO donor NOR-4 suppressed CYP3A4 expression induced by 1,25(OH)2D3 in Caco-2 cells in contrast, it significantly induced c-myc gene expression. Treatment of Caco-2 cells with the c-myc antisense oligonucleotide reversed the inhibitory effect of NOR-4 on CYP3A4 expression induced by 1,25(OH)(2)D-3. These results suggest that the suppression of 1,25(OH)(2)D-3-induced CYP3A4 expression by NO is due to c-myc expression. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:99 / 108
页数:10
相关论文
共 26 条
  • [1] ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
  • [2] ANTONSON P, 1995, EUR J BIOCHEM, V232, P397, DOI 10.1111/j.1432-1033.1995.397zz.x
  • [3] Carlson TJ, 1996, MOL PHARMACOL, V49, P796
  • [4] CYTOKINES, ENDOTOXIN, AND GLUCOCORTICOIDS REGULATE THE EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IN HEPATOCYTES
    GELLER, DA
    NUSSLER, AK
    DISILVIO, M
    LOWENSTEIN, CJ
    SHAPIRO, RA
    WANG, SC
    SIMMONS, RL
    BILLIAR, TR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) : 522 - 526
  • [5] Hall Stephen D., 1999, Drug Metabolism and Disposition, V27, P161
  • [6] Inhibitory effect of nitric oxide on the induction of cytochrome P450 3A4 mRNA by 1,25-dihydroxyvitamin D3 in Caco-2 cells
    Hara, H
    Mitani, N
    Adachi, T
    [J]. FREE RADICAL RESEARCH, 2000, 33 (03) : 279 - 285
  • [7] AN OLIGOMER COMPLEMENTARY TO C-MYC MESSENGER-RNA INHIBITS PROLIFERATION OF HL-60 PROMYELOCYTIC CELLS AND INDUCES DIFFERENTIATION
    HOLT, JT
    REDNER, RL
    NIENHUIS, AW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) : 963 - 973
  • [8] IDENTIFICATION OF RIFAMPIN-INDUCIBLE P450IIIA4 (CYP3A4) IN HUMAN SMALL-BOWEL ENTEROCYTES
    KOLARS, JC
    SCHMIEDLINREN, P
    SCHUETZ, JD
    FANG, C
    WATKINS, PB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) : 1871 - 1878
  • [9] C-MYC REPRESSES TRANSCRIPTION IN-VIVO BY A NOVEL MECHANISM DEPENDENT ON THE INITIATOR ELEMENT AND MYC BOX-II
    LI, LH
    NERLOV, C
    PRENDERGAST, G
    MACGREGOR, D
    ZIFF, EB
    [J]. EMBO JOURNAL, 1994, 13 (17) : 4070 - 4079
  • [10] Minamiyama Y, 1997, J PHARMACOL EXP THER, V283, P1479